
About Abbott Global Point of Care
Abbott Global Point of Care is a publicly listed company based in Waukegan (United States) founded in 1900. Rapid diagnostics products and solutions for point-of-care testing are provided. The company has 2 employees. Abbott Global Point of Care has completed 12 acquisitions, including Binax, CanAm Care and Cholestech. Its website globalpointofcare.abbott draws about 622 thousand monthly visits. Abbott Global Point of Care offers products and services including i-STAT CHEM8+ Cartridge, CHOLESTECH LDXâ„¢ Analyzer, Afinionâ„¢ 2, and Panbioâ„¢ COVID-19 Antigen Self-Test. Its focus areas include Diversified Medical Devices. Its legal entity is Abbott Rapid Diagnostics A/S.
Company details
Abbott Point of Care was founded in 1900 and is headquartered in Waukegan, United States. Operations focus on the medical diagnostics sector, with products developed for point-of-care testing worldwide. Services include COVID-19 antigen self-tests, glycated hemoglobin monitoring for diabetes management, and detection tools for infectious diseases. The companys domain supports global access to these diagnostic solutions.
- Headquarters Waukegan, United States
- Employees 2
- Stage Public
- SectorsHealthcare
- Website category Health
- Website globalpointofcare.abbott/us/en/index.html
- Social LinkedIn
- Legal Name Abbott Rapid Diagnostics A/S
- Annual Revenue$2.36 B (USD)-4as on Dec 31, 2016
- Net Profit$151.18 M (USD)-26as on Dec 31, 2016
- EBITDA$119.53 M (USD)-8as on Dec 31, 2016
- Latest Funding Round$37.76M (USD), Grant
Feb 2021
- Investors
- Employee Count2
- Investments & AcquisitionsBinax
& 11 more
Products & Services of Abbott Global Point of Care
Abbott Global Point of Care offers a comprehensive portfolio of products and services, including i-STAT CHEM8+ Cartridge, CHOLESTECH LDX™ Analyzer, Afinion™ 2, and Panbio™ COVID-19 Antigen Self-Test.
Delivers rapid blood chemistry and hematology results.
Provides lipid profile and glucose testing quickly.
Enables near-patient testing for various diagnostics.
Detects COVID-19 and influenza from a single swab.
Funding Insights of Abbott Global Point of Care
- Total Rounds 3
- Last Round Grant — $37.76M
- First Round $21M
(Jun 2000)
- Investors Count 1
All 3 funding rounds of Abbott Global Point of Care with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $37.76M | Grant | – | – | |
| Aug 2005 | Seed | – | – | – | |
| Jun 2000 | $21M | Debt – Conventional | – | – | – |
1 investors in total: 1 institutional.
Investors in Abbott Global Point of Care
Abbott Global Point of Care has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Abbott Global Point of Care
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Abbott Global Point of Care
Abbott Global Point of Care has strategically engaged in corporate development activities, having acquired 12 companies. Notable acquisitions include Binax, CanAm Care and Cholestech.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Drug research and development services are provided to biopharma firms. | concateno.com | Wynnum, Australia | 2015 | Jun 2009 | •••• | |
Healthcare services are provided since 1995 in the United States. | matria.com | Marietta, United States | 1995 | May 2008 | •••• | |
Healthcare solutions are delivered in the United States. | paradigmhealth.com | Upper Saddle River, United States | 1996 | Nov 2007 | $230M | |
Rapid Point-of-Care Coagulation analyzer | hemosense.com | San Jose, United States | 1997 | Nov 2007 | •••• | |
Protein-based point-of-care tests for biomarker detection are developed. | matritech.com | Newton, United States | 1996 | Aug 2007 | $36M | |
Point-of-care diagnostics solutions for chronic diseases | cholestech.com | San Diego, United States | 1988 | Jun 2007 | $326.3M | |
Immunodiagnostic testing kits are manufactured for medical diagnostics. | panbio.com.au | Brisbane, Australia | 0 | Jan 2007 | $37M | |
Develops, manufactures, and markets in vitro diagnostic tests for detecting cardiac ischemia. | ischemia.com | Waltham, United States | 1997 | Feb 2005 | $22.4M | |
POC products for infectious disease | binax.com | Portland, United States | 1986 | Feb 2005 | $43M | |
Developer of products for the management of osteoporosis | ostex.com | Seattle, United States | 2003 | Sep 2002 | •••• |
Complete acquisition details for Abbott Global Point of Care
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Abbott Global Point of Care
14 dated milestones of Abbott Global Point of Care across 121 years, from founding to its latest funding, stage changes and deals.
- Founded Abbott Global Point of Care is founded.
- Funding First funding round of $21.0M.
- Acquisition Acquires Ostex International.
- Acquisition Acquires Binax.
- Acquisition Acquires Ischemia Technologies.
- Acquisition Acquires Panbio.
- Acquisition Acquires Cholestech.
- Acquisition Acquires Matritech.
- Acquisition Acquires HemoSense.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires ParadigmHealth.
- Acquisition Acquires Matria Healthcare.
- Acquisition Acquires Concateno.
- Funding Latest funding round, Grant, of $37.8M.
Web traffic of Abbott Global Point of Care
The website of Abbott Global Point of Care (globalpointofcare.abbott) receives about 622.2K visits a month and ranks #198,021 among all websites worldwide, #6,410 in Health.
- Monthly visits622.2K
▲ 148.3% vs previous month
- Unique visitors119.3K
per month
- Global rank#198,021
among all websites
- Category rank#6,410
Health · Health
- Bounce rate47%
- Pages per visit1.8
- Average visit47 sec
- DevicesDesktop 20% · Mobile 80%
Websites whose visitors overlap most with Abbott Global Point of Care. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
corelaboratory.abbott | corelaboratory.abbott | 100% | #459,476 | – | |
| citymd.com | 91% | 328K | #168,173 | View details | |
| abbott.com | 87% | 917.2K | #65,577 | View details | |
compunetlab.com | compunetlab.com | 83% | #763,235 | – | |
meinarztbedarf.com | meinarztbedarf.com | 83% | #438,906 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Abbott Global Point of Care
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diversified Medical Devices
3 companies that operate in the same segment as Abbott Global Point of Care (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | Minneapolis, Minnesota, United States | USD 36.36 B | 95,000 | ||
Wide range of medical devices | 1979 | Marlborough, Massachusetts, United States | USD 20.07 B | 53,000 | ||
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | New Brunswick, New Jersey, United States | USD 94.18 B | 139,800 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Abbott Global Point Of Care
Complete news archive for Abbott Global Point of Care
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abbott Global Point of Care
Abbott Global Point of Care was founded in 1900 and raised its 1st funding round 100 years after it was founded.
Abbott Global Point of Care is headquartered in Waukegan, United States. It is registered at Waukegan, Illinois, United States.
Abbott Global Point of Care has 2 employees.
Annual revenue of Abbott Global Point of Care is $2.36B as on Dec 31, 2016.
Abbott Point of Care was founded in 1900 and is headquartered in Waukegan, United States. Operations focus on the medical diagnostics sector, with products developed for point-of-care testing worldwide. Services include COVID-19 antigen self-tests, glycated hemoglobin monitoring for diabetes management, and detection tools for infectious diseases. The companys domain supports global access to these diagnostic solutions.
Abbott Global Point of Care offers i-STAT CHEM8+ Cartridge, CHOLESTECH LDXâ„¢ Analyzer, Afinionâ„¢ 2, and Panbioâ„¢ COVID-19 Antigen Self-Test.
Abbott Global Point of Care has made 12 acquisitions, including Binax, CanAm Care, and Cholestech.
Abbott Global Point of Care has 1 investor. Key investors include European Union.
Abbott Global Point of Care operates through Abbott Rapid Diagnostics A/S.
The website of Abbott Global Point of Care receives about 622 thousand visits a month and ranks #198,021 among all websites worldwide.
